Deal Library / Pharma BD Deal Intelligence

H. Lundbeck A/S — Pharma Deals

The Pharma Closeout tracks 3 deals, $5.7B in disclosed deal value, 2 with a post-close Outcome Score for H. Lundbeck A/S.

Median Critic Score: 54  ·  Median Outcome Score: 42

Best outcome: H. Lundbeck A/S / Longboard Pharmaceuticals, Inc. (71)  ·  Weakest outcome: H. Lundbeck A/S / Prexton Therapeutics BV (14)

All 3 deals

• H. Lundbeck A/S / Longboard Pharmaceuticals, Inc. — 2024 · $2.6B · Largely worked — most objectives met.
• H. Lundbeck A/S / Prexton Therapeutics BV — 2018 · $1.1B · Did not work — the deal failed to deliver.
• H. Lundbeck A/S / Alder BioPharmaceuticals, Inc. — 2019 · $1.9B

← Deal Library  ·  Interactive search  ·  How we score deals